{"result": "(\"entity\"<|>IST<|>ORGANIZATION<|>IST refers to the Iron Saturation Test, a diagnostic tool used to measure the amount of iron in the blood and assess iron overload conditions.)\n##\n(\"entity\"<|>FERRITINA<|>ORGANIZATION<|>Ferritina is a protein that stores iron in the body and is used as a biomarker to evaluate iron levels and diagnose conditions like hemochromatosis.)\n##\n(\"entity\"<|>HH<|>EVENT<|>Hemochromatosis hereditary (HH) is a genetic disorder characterized by excessive iron accumulation in the body, leading to various health complications.)\n##\n(\"entity\"<|>C282Y<|>PERSON<|>C282Y is a specific mutation in the HFE gene associated with hereditary hemochromatosis, particularly in homozygous individuals.)\n##\n(\"entity\"<|>H63D<|>PERSON<|>H63D is another mutation in the HFE gene that can be present in heterozygous form and is associated with hereditary hemochromatosis.)\n##\n(\"entity\"<|>BLOQUE: METABOLISMO<|>ORGANIZATION<|>BLOQUE: METABOLISMO refers to a section or block in the document discussing metabolic processes related to iron metabolism and hemochromatosis.)\n##\n(\"entity\"<|>FAMILIARES DE 1ER GRADO<|>PERSON<|>First-degree relatives of patients with HH are individuals such as parents and siblings who may also be at risk for the genetic condition.)\n##\n(\"entity\"<|>HEPATOMEGALIA<|>EVENT<|>Hepatomegaly is the enlargement of the liver, which can be a clinical sign of liver disease, including conditions related to iron overload.)\n##\n(\"entity\"<|>FERRITINA ELEVADA<|>EVENT<|>Elevated ferritin levels indicate an excess of iron in the body and can be a sign of hemochromatosis or other iron overload disorders.)\n##\n(\"entity\"<|>BIOPSIA HEPÁTICA<|>EVENT<|>Liver biopsy is a medical procedure used to obtain liver tissue for diagnostic purposes, particularly in assessing liver damage or disease.)\n##\n(\"relationship\"<|>C282Y<|>HH<|>C282Y mutation is a genetic marker that indicates a high risk of developing hereditary hemochromatosis<|>9)\n##\n(\"relationship\"<|>H63D<|>HH<|>H63D mutation can contribute to the risk of hereditary hemochromatosis when combined with C282Y<|>7)\n##\n(\"relationship\"<|>IST<|>FERRITINA<|>IST and ferritina are both tests used to evaluate iron levels in the body and diagnose iron overload conditions<|>8)\n##\n(\"relationship\"<|>FAMILIARES DE 1ER GRADO<|>HH<|>First-degree relatives of patients with HH are recommended to undergo genetic testing due to their increased risk<|>6)\n##\n(\"relationship\"<|>HEPATOMEGALIA<|>HH<|>Hepatomegaly is a clinical sign that may indicate the presence of hereditary hemochromatosis<|>5)\n##\n(\"relationship\"<|>FERRITINA ELEVADA<|>HH<|>Elevated ferritin levels are a key indicator in diagnosing hereditary hemochromatosis<|>8)\n##\n(\"relationship\"<|>BIOPSIA HEPÁTICA<|>HH<|>Liver biopsy is performed to assess liver damage in patients diagnosed with hereditary hemochromatosis<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: por IST o ferritina elevadas, o con\nconcentraciones de hierro elevadas en las biopsias he-\npáticas. Solo la mutación C282Y con carácter homoci-\ngoto y la H63D en estado heterocigoto combinada con\nla C282Y (genotipo C282Y/H63D) deberían considerar-\nse indicativos de HH. Supera las limitaciones que pue-\nden presentar el IST o los otros parámetros del hierro\ninfluidos por el estado nutricional, pérdidas de sangre\nu otros factores ambientales o genéticos26.\n\nBiopsia hepática: Se debe realizar actualmente en\ndos situaciones. Una con valor diagnóstico cuando exis-\nte sospecha clínica o bioquímica y el estudio genético\nno es compatible con HH. Y otra con valor pronóstico\n---\n418      BLOQUE: METABOLISMO\n\n```mermaid\ngraph TD\n    A[IST Ferritina] --> B[IST < 45% Ferritina normal]\n    A --> C[IST > 45% y/o Ferritina elevada]\n    B --> D[No precisa más evaluación]\n    C --> E[Estudio genético del HFE]\n    F[Familiares de 1er grado de pacientes con HH] --> E\n    E --> G[- C282Y/C282Y]\n    E --> H[- C282Y/H63D<br>- Heterocigoto C282Y<br>- HH no relacionada<br>con el gen HFE]\n    G --> I[HH tipo 1<br>Ferritina < 1000 ng/ml<br>y ALT/AST normales]\n    G --> J[HH tipo 1<br>Ferritina > 1000 ng/ml<br>o↑ ALT y/o AST]\n    I --> K[Flebotomías sin<br>necesidad de<br>biopsia hepática]\n    J --> L[Biopsia hepática<br>para estudio<br>histopatológico e<br>IHH]\n    L --> M[Flebotomías]\n    H --> N[Excluir otras causas<br>hepáticas o hematológicas<br>de sobrecarga férrica<br>+/- Biopsia hepática<br>diagnóstica (IHH) y con<br>valor pronóstico]\n    N --> O[IHH > 1,9<br>μmol/g/años*]\n    N --> P[IHH < 1,9<br>μmol/g/años*]\n    O --> Q[Compatible con<br>HH diferente de<br>la tipo 1 o<br>mutaciones raras<br>del HFE]\n    P --> R[Otras causas<br>de sobrecarga<br>férrica<br>diferentes<br>de HH]\n```\n\nIHH: índice hepático de hierro\n\n\\* μmol de Fe/g de tejido hepático seco/edad del paciente en años\n\nFuente: Bacon et al. Hepatology. 2011; 54:328-43.\n\nFigura 1. Algoritmo diagnóstico y terapéutico de la hemocromatosis hereditaria (HH).\n---\nTema 25. Anemia y hemocromatosis. Dieta controlada en hierro 419\n\ncuando tenemos confirmación diagnóstica genética y alta probabilidad de lesión hepática (fibrosis o cirrosis) determinada por hepatomegalia, aumento de transaminasas o ferritina mayor de 1000 ng/ml. La biopsia hepática se puede evitar en los homocigotos C282Y cuando la ferritina es < 1.000 ng/ml y no existe elevación de transaminasas, dado que en estos casos se puede predecir la ausencia de cirrosis26.\n\nLa fibrosis hepática suele ocurrir cuando hay entre 5-10 g de hierro acumulado, sobre todo si hay otros factores añadidos como alcoholismo o hepatitis vírica asociados.\n\n### Estudio familiar y poblacional33, 26:\nUna vez que un paciente con HH se ha identificado (caso índice), se recomienda realizar a padres y hermanos el estudio tanto del genotipo (mutación HFE) como del fenotipo (ferritina e IST). También se recomienda realizar el estudio genético al cónyuge de dicho caso índice, y si este es portador sano, proceder al análisis genético de todos los hijos, ya que tienen un 50% de riesgo de heredar la mutación en homocigosis. Ante un paciente homocigoto C282TY/C282Y y un cónyuge no portador se puede deducir que todos los hijos son portadores heterocigotos (C282Y/normal) no enfermos. Si el cónyuge es portador sano en heterocigosis (C282Y/normal) el 50% de los hijos serán homocigotos C282TY/C282Y, teniendo un riesgo muy elevado de desarrollar la enfermedad (según penetrancia 70%) y por lo tanto será necesario determinar el IST y la ferritina sérica anualmente. El otro 50% serán portadores sanos heterocigotos (C282Y/normal).\n\nPara el cribado poblacional tiene menos valor el estudio genético, dado que la penetrancia es incompleta (\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}